Like other industrialized countries, Australia is facing major population ageing. From 2000 to 2025, the number of Australians aged 65 years and over will more than double, as a result of the ageing of the baby boom cohort and increasing life expectancy, while the number of people in working age groups will decline. 1 To guide constructive responses to this unprecedented change, the Government's Minister on Ageing released the National Strategy for an Ageing Australia 2 which set key issues for national policy development, to be underpinned by policy. In 2003, the Australian Prime Minister's Science, Engineering and Innovation Council (PMSEIC) brought together leading researchers and policymakers who prepared a report articulating an evidence-based vision for healthy ageing in Australia and an associated programme of longitudinal research to guide the achievement of 'an additional 10 years of healthy life expectancy' by 2050. 2 That same year, the Australian government established 'Ageing Well, Ageing Productively' as a National Research Priority goal. In 2004 the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC) funded national research networks including the Research Network in Ageing Well (RNAW) to lead and facilitate collaboration in multidisciplinary large scale research on ageing, build research capacities and international collaborations, and improve communication and translation with key constituencies (www.ageingwell.edu.au).
In 2004, the NHMRC and ARC announced a strategic funding initiative to facilitate research into ageing that is multisectorial, multidisciplinary and cross-institutional. The goal of this was to develop an authoritative evidence base for policy and practice in the priority area of Ageing Well, Ageing Productively. Collaborators from nine Australian Longitudinal Ageing studies, together with demographers, statistical and modelling experts, subsequently proposed the Dynamic Analyses to Optimize Ageing (DYNOPTA) project which received funding for a 5-year programme grant that commenced in 2007. The broad aims of DYNOPTA reflect the vision of the PMSEIC report to identify effective pathways to compressing morbidity and optimizing ageing.
DYNOPTA has constructed a pooled dataset comprising information from nine Australian Longitudinal Studies of Ageing (LSA). [3] [4] [5] [6] [7] [8] [9] Data were harmonized from the contributing studies (described in Table 1) to 12 and the alcohol consumption data have been harmonized to provide classifications in accordance with those endorsed by the National Health and Medical Research Council. 13 What does DYNOPTA cover?
The research programme focuses on four outcomes that contribute greatly to the burden of disease and disability, namely dementia and cognition, mental health, sensory impairment and mobility/activity limitations. Mortality is also included as a key outcome. The four health domains were chosen from recent research into the principal factors contributing to disease burden, or studies of the impact of diseases or conditions leading to injury, disability/impairment or premature death. Lopez and colleagues 14 found that Alzheimer disease and other dementias, depressive disorders, hearing loss and conditions such as osteoarthritis were among the top 10 leading causes of burden of disease with loss of healthy-life years in higher income countries worldwide. Similar findings were made in a recent report from the Australian Institute of Health and Welfare. 15 The DYNOPTA dataset also includes key sociodemographic variables such as marital and partner status, labour force participation and date of death. In addition to being risk factors for the four outcomes, analyses of these will enable a more detailed understanding of demographic and social processes in later life. The research programme is underpinned by an interdisciplinary life course approach to human development and ageing that recognizes interdependencies among demographic, social, lifestyle, economic and health factors. 16, 17 Who is in the sample?
The geographic scope of the sample is shown in Figure 1 . Of the nine contributing studies, three are nationally representative, comprising 65% of participants at baseline. The remaining six studies are based in specific Australian cities or regions, including Adelaide, the Blue Mountains, the Australian Capital Territory (ACT) and Queanbeyan, Melbourne and Sydney. Most of the sample (90%) live in either highly accessible or accessible areas (i.e. access to metropolitan services) according to the Australian Standard Geographical Classification system. 18 The sample comprises 50 652 baseline participants (wave 1 of each study between 1990 and 2001). Of these, 39 085 (77.2%) were female, reflecting inclusion of the all-female Australian Longitudinal Study of Women's Health (particularly for the 45-54 and 65-74 age groups), and women's greater longevity. Selected sample characteristics are shown in Table 2 . This reports frequency of participants' characteristics as a proportion of the baseline sample. In the baseline sample, a total of 69.5% participants were married or partnered, while 16.7% were widowed with increasing proportions of widowed participants at older ages. About half of those with available data at baseline were in the workforce. Only 0.3% had no formal education, and 10.3% reported having attained tertiary education.
Selected health characteristics and social contact are reported in Table 3 . On a self-reported health measure, 35.9% reported their health as excellent and 3.0% as poor. Of those with available data, about half (52%) reported having never smoked. Of those with visual acuity data, 3% were classified with a visual impairment. Of the baseline sample data reporting information on social contact, 68.6% reported face to face contact with friends or family at least once per week.
What is included in the pooled dataset?
The pooled dataset contains demographic information, outcome variables for the four key domains (cognition, mental health, physical disability and sensory function) and data on risk factors and health behaviours. The risk factors include other medical conditions (e.g. arthritis, hypertension) as well as psychosocial measures, such as social networks. Mortality data are also included, as well as Percentages reported for the full sample and do not add to 100% due to missing data.
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self-reported use of services. Table 4 lists the domains included in the dataset.
How often have they been followed?
The number and dates of waves for each study are shown in Table 1 . Studies have an average of 4.4 waves over an average period of 9.4 years (SD ¼ 2.99), though this is inflated by MELSHA with 11 waves over 12 years, and by ALSA with seven waves over 11 years. The mean number of surveys completed by each participant was 3.1 (SD ¼ 1.51), with a mode of 4 and median of 3 surveys per participant.
Development of weights for the DYNOPTA dataset
The contributing studies use a variety of survey designs and differ in their geographic and demographic coverage. Some surveys are results of simple random samples, for others stratified, or cluster designs were used. The demographic coverage also differs between studies. Estimation weights are being developed for DYNOPTA that will reflect the different sample sizes and selection probablities of the studies and ensure that the different studies are approriately combined when they cover the same geographical and demographic subpopulations. Other complexities of the design will also have to be accounted for in analyses and any study effects identified and adjustments made.
How were data harmonized?
Data were mostly harmonized using the 'by fiat' method. [19] [20] [21] [22] This method assumes a common scoring system across studies [19] [20] [21] [22] and is recommended when the possibility of dispute is small, the number of categories is relatively consistent across studies and a clear authority can endorse the system. In some instances, variables were harmonized at several levels. The most generic level is most inclusive of the largest number of participants, while a more detailed level would be that which is most inclusive of information, but which may result in the inclusion of fewer participants. A latent variable approach is being used to harmonize different depression measures.
Due to the nature of the studies that contributed to the creation of the pooled dataset, coverage of information varies considerably across the total sample. For example, at the first measurement occasion (wave 1 for all studies), self-rated health is available for 44 224 participants, whilst information about visits to a general practitioner is available for only half that number (n ¼ 28 639).
What are the main strengths and weaknesses of DYNOPTA?
A major strength of this innovative study is the large sample size and multiple occasions of measurement. The increase in statistical power enables more reliable analyses than has hitherto not been possible in the Australian setting. This allows for the study of conditions that are relatively rare such as Parkinson disease, or for those conditions that Australian policy makers had previously relied on European data (e.g. Dementia 15 ). The study also provides data on under-represented groups, for whom comparisons are often not feasible due to small sample sizes (e.g. adults aged 85þ). The inclusion of cohorts studied at varying points of time will allow for the evaluation of cohort effects.
The national coverage of this large sample adds to the utility of the findings as does the depth and breadth of this dataset. Although some epidemiological studies with large datasets include information gained purely from mailed questionnaires, limiting the type of data collected, a significant proportion of the data included in DYNOPTA is based on personal interview and assessments. Another strength of the study is the development of the infrastructure, documentation of Australian longitudinal research and the development of methodologies for harmonization. This will facilitate future research involving the harmonization of the DYNOPTA dataset with other Australian sources, and international sources such as U.S. Health and Retirement Survey, 23 the Surveys of Health and Retirement in Europe 24 and the Comparison of Longitudinal European Studies on Aging (CLESA) which has undertaken a similar harmonization and pooling approach to analyse data from six longitudinal studies. 25 The pooled dataset does however have limitations.
As not all contributing datasets were nationally representative, the sample needs to be weighted to produce population estimates. Most of the data on medical conditions is self-report although clinical data are available for sensory function, blood pressure, cognition, grip strength and some other functional measures. There is variability in the sampling methods used by the contributing studies, the inclusion and exclusion criteria, and modes of survey administration and this potential for heterogeneity will need to be tested and adjusted for. Finally, as with all longitudinal studies of ageing, there is sample attrition and missing data due to withdrawal, mortality and other non-response that increases with each occasion of measurement.
What are some of the anticipated research questions and implications for the DYNOPTA project?
With the breadth of domains assessed and the extent of longitudinal data, DYNOPTA will provide a unique window through which to investigate ways to optimize ageing outcomes, using an interdisciplinary approach. Epidemiological analyses of the pooled dataset will identify key incidence rates and risk factors for the targetted health outcome areas, as well as for mortality.
Longitudinal analyses will model the transition from states of health to states of disability. These transitions will be used in the construction of a dynamic microsimulation model that will also allow for the costs of disability to be estimated. Scenarios involving modification of risk factors and rates of disability will be evaluated to inform Australian policy makers. One goal is to estimate the expected years of disabilityfree life expectancy within each targetted health outcome area. The DYNOPTA dataset will also provide an excellent platform in cross-national analyses. 20 Similar longitudinal datasets from Europe and the United States offer the opportunity to explore COHORT PROFILE: THE DYNAMIC ANALYSES TO OPTIMIZE AGEING (DYNOPTA) PROJECT similarities and differences in ageing trajectories in countries with broadly similar populations, including the impact of particular policies, such as different retirement ages.
Where can I find out more?
Further information is available on the DYNOPTA website http://DYNOPTA.anu.edu.au. The pooled dataset is governed by a Collaborative Research Agreement among several institutions. The first version of the dataset was released in November 2008. Those interested in collaborating on the project can contact the Scientific Committee at DYNOPTA@anu.edu.au.
